SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CuraGen (CRGN)
An SI Board Since March 1998
Posts SubjectMarks Bans Symbol
478 35 0 CRGN
Emcee:  Superhawk Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
303NEW HAVEN, Conn., Nov. 7 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: nigel bates-11/7/2002
302CuraGen Establishes Collaboration with Mitsubishi in Schizophrenia NEW HAVEN, Cnigel bates-11/5/2002
301Cool. And you snagged 300. Talking of ADMET, but somewhat OT for CRGN (but as nigel bates-10/27/2002
300>>NEW HAVEN, Conn., Oct. 23 /PRNewswire-FirstCall/ -- CuraGen Corporation tuck-10/23/2002
299Genomeweb on '454' - <i>After Two Years in Ultra-Stealth Mode, 45nigel bates-10/3/2002
298NEW HAVEN, Conn., Oct. 2 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: nigel bates-10/2/2002
297<i>We believe this to be the most likely scenario because of the shear numDoc Bones-9/19/2002
296It would appear that the street is now regarding R&D as an expense rather thIan@SI-9/19/2002
295<i>We believe this to be the most likely scenario because of the shear numnigel bates-9/19/2002
294>>NEW YORK--(BUSINESS WIRE)--Sept. 19, 2002--The Wall Street Transcript hatuck-9/19/2002
293LEVERKUSEN, Germany and NEW HAVEN, Conn., Sept. 18 /PRNewswire-FirstCall/ -- Baynigel bates-9/18/2002
292listened to a little bit of the conference call. seemed like continued pie in thMadharry-7/25/2002
291PAT. NO. Title 1 6,395,478 Identification and comparison of protein-protein intJim Oravetz-5/30/2002
290United States Patent 6,372,490 Nandabalan , et al. April 16, 2002 Nucleic aJim Oravetz-5/30/2002
289United States Patent 6,395,478 Nandabalan , et al. May 28, 2002 IdentificatJim Oravetz-5/30/2002
288Region's biotech boom could bring bad news Luther Turmelle, Register BusinesJim Oravetz-5/30/2002
287The abstract: >>A Novel Human Growth Factor, FGF-20, Is Active in Animal tuck-5/21/2002
286CuraGen Announces CG53135 Protein Demonstrates Reproducible Efficacy in Multiplenigel bates-5/21/2002
285CuraGen and Abgenix Scientists Develop Fully Human Monoclonal Antibodies to PDGFnigel bates-5/2/2002
284CuraGen Down 13%; Company Postpones Clinical Trials DOW JONES NEWSWIRES By John Jim Oravetz-4/26/2002
283NEW HAVEN, Conn., April 25 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaqnigel bates-4/25/2002
282I am considering trying to go to the shareholders meeting next month in WestbrooJim Oravetz-4/22/2002
281Unique Activity of Anti-Angiogenic Protein Revealed at the 93rd Annual American nigel bates-4/9/2002
280Branford approves CuraGen campus Michelle Tuccitto, Register Staff April 05, Jim Oravetz-4/5/2002
279Fearing Unsolicited Takeover, CuraGen Adopts Stockholder Rights Plan By a GenomJim Oravetz-3/29/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News